Inhibition of influenza A virus infection by ginsenosides.
Influenza viruses cause mild to severe respiratory infections in humans. Due to efficient means of transmission, the viruses infect human population on a large scale. Apart from vaccines, antiviral drugs are used to control infection; neuraminidase inhibitors are thought to be the first choice of tr...
Main Authors: | Wei Dong, Amber Farooqui, Alberto J Leon, David J Kelvin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171936&type=printable |
Similar Items
-
Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process
by: Yingna Huang, et al.
Published: (2022-12-01) -
Influenza Virus Infection Model With Density Dependence Supports Biphasic Viral Decay
by: Amanda P. Smith, et al.
Published: (2018-07-01) -
Inhibition of influenza A virus infection in vitro by peptides designed in silico.
by: Rogelio López-Martínez, et al.
Published: (2013-01-01) -
Back to the Future for Influenza Preimmunity—Looking Back at Influenza Virus History to Infer the Outcome of Future Infections
by: Magen Ellen Francis, et al.
Published: (2019-01-01) -
Corrigendum: Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection
by: Thrimendra Kaushika Dissanayake, et al.
Published: (2020-10-01)